{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:54:55Z","timestamp":1786737295842,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jpbs.jpbs_47_20","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T07:15:33Z","timestamp":1597994133000},"page":"151","source":"Crossref","is-referenced-by-count":6,"title":["Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws"],"prefix":"10.4103","volume":"12","author":[{"given":"NasserR","family":"Alqhtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdulrahmanK","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaisalA","family":"Zuhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AdelA","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdullahBin","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.292872-1","unstructured":"Kurien J, Sunil EA, Mukunda A, Philip SR An update on bisphosphonate-related osteonecrosis of the jaw. Indian J Clin Pract 2013;24:267-70."},{"key":"key-10.4103\/0975-7406.292872-2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/0975-7406.292872-3","doi-asserted-by":"crossref","unstructured":"Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005;136:1658-68.","DOI":"10.14219\/jada.archive.2005.0108"},{"key":"key-10.4103\/0975-7406.292872-4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(93)90282-T","article-title":"Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages","author":"Nussbaum","year":"1993","journal-title":"Am J Med"},{"key":"key-10.4103\/0975-7406.292872-5","first-page":"3483","article-title":"Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors","author":"Van","year":"2013","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0975-7406.292872-6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0975-7406.292872-7","doi-asserted-by":"crossref","unstructured":"Watts NB Bisphosphonate treatment of osteoporosis. Clin Geriatr Med 2003;19:395-414.","DOI":"10.1016\/S0749-0690(02)00069-1"},{"key":"key-10.4103\/0975-7406.292872-8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","author":"Bishop","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/0975-7406.292872-9","doi-asserted-by":"crossref","unstructured":"Ralston SH, Langston AL, Reid IR Pathogenesis and management of Paget\u2032s disease of bone. Lancet 2008;372:155-63.","DOI":"10.1016\/S0140-6736(08)61035-1"},{"key":"key-10.4103\/0975-7406.292872-10","doi-asserted-by":"crossref","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65:2397-410.","DOI":"10.1016\/j.joms.2007.08.003"},{"key":"key-10.4103\/0975-7406.292872-11","doi-asserted-by":"crossref","unstructured":"Vinitzky-Brener I, Ib\u00e1\u00f1ez-Mancera N-G, \u00c1lvarez-Jard\u00f3n A-P Knowledge of bisphosphonate-related osteonecrosis of the jaws among Mexican dentists. Med Oral Patol Oral Cir Bucal 2017;22:e84-7.","DOI":"10.4317\/medoral.21433"},{"key":"key-10.4103\/0975-7406.292872-12","doi-asserted-by":"crossref","unstructured":"Alhussain A, Peel S, Dempster L, Clokie C, Azarpazhooh A Knowledge, practices, and opinions of Ontario dentists when treating patients receiving bisphosphonates. J Oral Maxillofac Surg 2015;73:1095-105.","DOI":"10.1016\/j.joms.2014.12.040"},{"key":"key-10.4103\/0975-7406.292872-13","doi-asserted-by":"crossref","unstructured":"Rosella D, Papi P, Pompa G, Capogreco M, De Angelis F, Di Carlo S Dental students\u2019 knowledge of medication-related osteonecrosis of the jaw. Eur J Dent 2017;11:461-8.","DOI":"10.4103\/ejd.ejd_27_17"},{"key":"key-10.4103\/0975-7406.292872-14","doi-asserted-by":"crossref","unstructured":"Escobedo M, Garc\u00eda-Consuegra L, Junquera S, Olay S, Ascani G, Junquera L Medication-related osteonecrosis of the jaw: a survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain). J Stomatol Oral Maxillofac Surg 2018;119:395-400.","DOI":"10.1016\/j.jormas.2018.04.008"},{"key":"key-10.4103\/0975-7406.292872-15","doi-asserted-by":"crossref","unstructured":"Al-Samman AA, Al-Ani RS Across-sectional survey on medication-related osteonecrosis of the jaws\u2032 knowledge and awareness in a sample of dental society. J Cranio-Maxillofac Surg 2019;47:926-31.","DOI":"10.1016\/j.jcms.2019.02.006"},{"key":"key-10.4103\/0975-7406.292872-16","doi-asserted-by":"crossref","unstructured":"Sturrock A, Preshaw PM, Hayes C, Wilkes S Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England. BMJ Open 2019; 9:e024376.","DOI":"10.1136\/bmjopen-2018-024376"}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:41Z","timestamp":1786733561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.JPBS_47_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["292872"],"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_47_20","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}